Contractor directory
UEI MUM1EGCDWZJ4 · CAGE 1H0B6

Emergent Biodefense Operations Lansing LLC

Emergent Biodefense Operations Lansing LLC received $21.5M in federal prime contract obligations in the 12 months ending Oct 5, 2026, up 3.5% from $20.8M the year before, and $93.8M since FY2022. Its largest customer is the Department of Defense.

Obligations, latest 12 months
$21.5M
up 3.5% vs. $20.8M
Since FY2022
$93.8M
6 awards
Awards with activity
2
Latest 12 months
Most recent action
Apr 10, 2026
First seen Oct 26, 2021

Contractor details

Unique Entity ID (UEI)
MUM1EGCDWZJ4
CAGE code
1H0B6
Headquarters
Lansing, MI
Business size
Small Business
Parent company
Emergent Biosolutions Inc (UEI DKEFA8JAW3X4)

As recorded on this UEI's most recent prime contract action in USAspending.gov. Confirm current registration and certifications in SAM.gov.

Obligations by fiscal year

Net prime contract obligations by federal fiscal year.

FY2022
$30.5M
FY2023
−$10K
FY2024
$21.0M
FY2025
$20.8M
FY2026
$21.5M

Markets where it ranks top 10

Agency and NAICS markets where this UEI is one of the ten largest primes in the latest 12 months.

Top agencies

Funding agencies ranked by obligations since FY2022.

Funding agencyLatest 12 moSince FY2022
Department of Defense$21.5M$63.3M
Department of Health and Human Services$3K$30.5M

Top NAICS codes

Industry codes agencies recorded on this contractor's awards, since FY2022.

NAICSIndustryLatest 12 moSince FY2022
325411Medicinal and Botanical Manufacturing$21.5M$63.3M
325414Biological Product (except Diagnostic) Manufacturing$0$21.2M
541711Research and Development in Biotechnology$0$9.2M
325412Pharmaceutical Preparation Manufacturing$3K$139K

What it sells

Product and service codes (PSC) on this contractor's awards, since FY2022.

PSCDescriptionSince FY2022
6505Drugs and Biologicals$84.7M
C118Research and Development Facilities$9.2M

Recent awards

This contractor's newest prime contract awards, most recent first.

AwardAgencyObligatedAwarded
75D30126P20965
Department of Health and Human Services
BIO THRAX VACCINE
$3KApr 10, 2026
W911SR26FA005
Department of Defense
FOR THE PROCUREMENT OF BIOTHRAX (ANTHRAX VACCINE ABSORBED (AVA))
$7.2MJan 8, 2026
W911SR24F0016
Department of Defense
PROCUREMENT OF BIOTHRAX (ANTHRAX VACCINE ADSORBED)
$6.5MJan 19, 2024
75A50322P00016
Department of Health and Human Services
ANNUAL POTENCY TESTING OF THE WETVAX (APSV) VIALS STORED AT THE SNS.
$146KMay 3, 2022

Other Emergent Biosolutions Inc entities

UEIs that report the same ultimate parent in SAM.gov. Ownership records can lag acquisitions.

Prime contracts (award types A–D) from USAspending.gov through Oct 5, 2026. Subcontracts are not included. Net obligations include deobligations and corrections.

Ready to win more?

Ready to connect your pursuit work?

GovEagle gives BD directors, capture managers, and proposal teams one AI workspace from pipeline through proposal, with CMMC/FedRAMP Certified compliance built in.